Cell Marker Predictors in Barrett's Esophagus
NCT03316053 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2026-01-07
Summary
The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.
Conditions
- Barrett's Esophagus Without Dysplasia
Interventions
- OTHER
-
Tissue sample for genetic testing
Tissue sample to be obtained during routine endoscopy
Sponsors & Collaborators
-
The Guthrie Clinic
lead OTHER
Principal Investigators
-
Michael Georgetson, MD · The Guthrie Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-15
- Primary Completion
- 2026-12-01
- Completion
- 2027-12-01
Countries
- United States
Study Locations
More Related Trials
-
Barrett's Esophagus & Gastroesophageal Reflux Disease
NCT00513331 ·Status: COMPLETED
-
Prevalence of Human Papillomavirus in Barrett Esophagus Compared With Controls
NCT02549053 ·Status: COMPLETED ·Phase: NA
-
Screening for Barrett's Esophagus in Otolaryngology Patients
NCT00695227 ·Status: COMPLETED ·Phase: NA
-
Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus
NCT04301986 ·Status: COMPLETED ·Phase: NA
-
The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus
NCT01905202 ·Status: UNKNOWN ·Phase: PHASE1
-
Influence of Acid Reflux on Stromal Epithelial Interaction in Barrett's Esophagus
NCT01281618 ·Status: COMPLETED
-
Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus
NCT00005878 ·Status: COMPLETED ·Phase: PHASE2
-
Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus
NCT00526786 ·Status: TERMINATED ·Phase: PHASE4
-
Cytosponge Adequacy Study Evaluation II
NCT02395471 ·Status: COMPLETED ·Phase: NA
-
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
NCT01097304 ·Status: COMPLETED ·Phase: PHASE2
-
Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease
NCT01572974 ·Status: TERMINATED
-
Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus
NCT00573911 ·Status: COMPLETED ·Phase: PHASE1
-
Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?
NCT01865825 ·Status: COMPLETED
-
A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy
NCT01845454 ·Status: TERMINATED ·Phase: NA
-
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
NCT05753748 ·Status: RECRUITING ·Phase: NA
-
Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus
NCT01298999 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Studies on Bile Acids in Barrett's Esophagus
NCT00858858 ·Status: COMPLETED ·Phase: NA
-
Characterization of the Neo-squamous Epithelial Barrier
NCT03077594 ·Status: COMPLETED
-
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease
NCT03005080 ·Status: COMPLETED
-
In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter
NCT00737802 ·Status: TERMINATED
-
Comparative Effectiveness of Endoscopic Assessment of Gastroesophageal Reflux and Barretts Esophagus
NCT01288612 ·Status: COMPLETED ·Phase: NA
-
Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
NCT03822325 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer
NCT00321958 ·Status: TERMINATED
-
The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus
NCT03193216 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
NCT00703534 ·Status: COMPLETED ·Phase: PHASE2